Phase III Adjuvant Trial in Pancreatic Cancer Comparing 5FU and D-L-Folinic Acid vs. Gemcitabine.
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Gemcitabine (Primary) ; Fluorouracil; Folinic acid
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ESPAC-3
- 08 Mar 2018 Results of an analysis assessing the intra-tumoural dihydropyrimidine dehydrogenase expression status in patient population from this trial (n= 238), published in the British Journal of Cancer.
- 11 Jul 2012 Results published in JAMA: the Journal of the American Medical Association.
- 31 May 2012 New source identified and integrated (Australian New Zealand Clinical Trials Registry: ACTRN12605000361606)
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History